{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:45:10Z","timestamp":1757619910798,"version":"3.44.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Special and Joint Program of the Yunnan Provincial Science and Technology Department and Kunming Medical University","award":["No. 202201AY070001-265; No. 202301AY070001-189","No. 202201AY070001-265; No. 202301AY070001-189"],"award-info":[{"award-number":["No. 202201AY070001-265; No. 202301AY070001-189","No. 202201AY070001-265; No. 202301AY070001-189"]}]},{"name":"Famous Doctors of High level Talent Training Support Program of Yunnan Province","award":["No. YNWR-MY-2020-013; No. XDYC-YLWS-2023-0043","No. YNWR-MY-2020-013; No. XDYC-YLWS-2023-0043"],"award-info":[{"award-number":["No. YNWR-MY-2020-013; No. XDYC-YLWS-2023-0043","No. YNWR-MY-2020-013; No. XDYC-YLWS-2023-0043"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 82160016"],"award-info":[{"award-number":["No. 82160016"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Yunnan Provincial Innovation Team for Respiratory and Pulmonary Circulation Diseases","award":["No. 202405AS350018"],"award-info":[{"award-number":["No. 202405AS350018"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"DOI":"10.1186\/s12890-025-03815-6","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T07:16:05Z","timestamp":1753686965000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical characteristics of patients with acute pulmonary embolism complicated with antiphospholipid syndrome: a case control study"],"prefix":"10.1186","volume":"25","author":[{"given":"Jianyuan","family":"Wan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuanglan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingchao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiqian","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,28]]},"reference":[{"issue":"1","key":"3815_CR1","doi-asserted-by":"publisher","first-page":"53","DOI":"10.4046\/trd.2018.0045","volume":"82","author":"YS Na","year":"2019","unstructured":"Na YS, Jang S, Hong S, et al. Clinical phenotype of a first unprovoked acute pulmonary embolism associated with antiphospholipid antibody syndrome. Tuberc Respir Dis. 2019;82(1):53\u201361.","journal-title":"Tuberc Respir Dis"},{"issue":"4","key":"3815_CR2","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1002\/art.10187","volume":"46","author":"R Cervera","year":"2002","unstructured":"Cervera R, Piette JC, Font J, et al. Antiphospholipid syndrome: clinical and Immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum. 2002;46(4):1019\u201327.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"3815_CR3","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s10067-017-3549-1","volume":"36","author":"H Shi","year":"2017","unstructured":"Shi H, Teng JL, Sun Y, et al. Clinical characteristics and laboratory findings of 252 Chinese patients with anti-phospholipid syndrome: comparison with Euro-Phospholipid cohort. Clin Rheumatol. 2017;36(3):599\u2013608.","journal-title":"Clin Rheumatol"},{"issue":"2","key":"3815_CR4","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1136\/annrheumdis-2018-213846","volume":"78","author":"I Uthman","year":"2019","unstructured":"Uthman I, Noureldine MHA, Ruiz-Irastorza G, et al. Management of antiphospholipid syndrome. Ann Rheum Dis. 2019;78(2):155\u201361.","journal-title":"Ann Rheum Dis"},{"issue":"19","key":"3815_CR5","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1182\/blood-2017-09-805689","volume":"131","author":"C Kearon","year":"2018","unstructured":"Kearon C, Parpia S, Spencer FA, et al. Antiphospholipid antibodies and recurrent thrombosis after a first unprovoked venous thromboembolism. Blood. 2018;131(19):2151\u201360.","journal-title":"Blood"},{"issue":"1","key":"3815_CR6","doi-asserted-by":"publisher","first-page":"e471","DOI":"10.1016\/j.repc.2018.01.015","volume":"39","author":"C Sep\u00falveda","year":"2020","unstructured":"Sep\u00falveda C, Repolho D, Antunes AM, et al. Dyspnea in antiphospholipid syndrome: beyond pulmonary embolism. Rev Port Cardiol. 2020;39(1):e471-47.e5.","journal-title":"Rev Port Cardiol"},{"key":"3815_CR7","doi-asserted-by":"publisher","first-page":"872523","DOI":"10.3389\/fcvm.2022.872523","volume":"9","author":"M Shi","year":"2022","unstructured":"Shi M, Gao W, Jin Y, et al. Antiphospholipid Syndrome-Related pulmonary embolism: clinical characteristics and early recognition. Front Cardiovasc Med. 2022;9:872523.","journal-title":"Front Cardiovasc Med"},{"key":"3815_CR8","first-page":"1060","volume":"14","author":"Chinese Thoracic Society Pulmonary Embolism and Pulmonary Vascular Disease Group, Pulmonary Embolism and Pulmonary Vascular Disease Working Committee, Respiratory Physician Branch of Chinese Medical Doctor Association, National collaboration group for the prevention and treatment of pulmonary embolism and pulmonary vascular disease","year":"2018","unstructured":"Chinese Thoracic Society Pulmonary Embolism and Pulmonary Vascular Disease Group, Pulmonary Embolism and Pulmonary Vascular Disease Working Committee, Respiratory Physician Branch of Chinese Medical Doctor Association, National collaboration group for the prevention and treatment of pulmonary embolism and pulmonary vascular disease. 2018 Chinese guidelines for the diagnosis, treatment, and prevention of pulmonary thromboembolism. Chin Med J. 2018;14:1060\u201387.","journal-title":"Chin Med J"},{"issue":"2","key":"3815_CR9","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","volume":"4","author":"S Miyakis","year":"2006","unstructured":"Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemostasis: JTH. 2006;4(2):295\u2013306.","journal-title":"J Thromb Haemostasis: JTH"},{"key":"3815_CR10","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3389\/fped.2018.00362","volume":"6","author":"C Wincup","year":"2018","unstructured":"Wincup C, Ioannou Y. The differences between childhood and adult onset antiphospholipid syndrome. Front Pead. 2018;6:362.","journal-title":"Front Pead"},{"issue":"12","key":"3815_CR11","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1157\/13067087","volume":"123","author":"MT Camps Garc\u00eda","year":"2004","unstructured":"Camps Garc\u00eda MT, Fern\u00e1ndez Nebro A, D\u00edaz Cobos C, et al. Clinical and immunological features in 112 patients with antiphospholipid syndrome. Med Clin. 2004;123(12):466\u201370.","journal-title":"Med Clin"},{"issue":"SI","key":"3815_CR12","doi-asserted-by":"publisher","first-page":"SI24","DOI":"10.1093\/rheumatology\/kead571","volume":"63","author":"P Gaspar","year":"2024","unstructured":"Gaspar P, Sciascia S, Tektonidou MG. Epidemiology of antiphospholipid syndrome: macro- and microvascular manifestations. Rheumatology (Oxford). 2024;63(SI):SI24\u201336.","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"3815_CR13","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1055\/a-2173-7729","volume":"44","author":"R Klamroth","year":"2024","unstructured":"Klamroth R, Riess H, Beyer-Westendorf J, et al. Recurrent venous thromboembolism in patients on anticoagulation: an update based on the revised AWMF S2k guideline. Hamostaseologie. 2024;44(2):150\u20134.","journal-title":"Hamostaseologie"},{"issue":"1","key":"3815_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pccm.2025.02.003","volume":"3","author":"BL Davidson","year":"2025","unstructured":"Davidson BL, Schryver ND. Pulmonary embolism prophylaxis and treatment: what\u2019s right, what\u2019s wrong, and the future. Chin Med J Pulmonary Crit Care Med. 2025;3(1):1\u20135.","journal-title":"Chin Med J Pulmonary Crit Care Med"},{"issue":"6","key":"3815_CR15","first-page":"1033","volume":"55","author":"LR Hong","year":"2023","unstructured":"Hong LR, Chen YJ, Jiang QL, et al. [Predictive value of four items of new thrombus markers combined with conventional coagulation tests for thrombosis in antiphospholipid syndrome]. Beijing Da Xue Xue Bao Yi Xue Ban = J Peking Univ Health Sci. 2023;55(6):1033\u20138.","journal-title":"Beijing Da Xue Xue Bao Yi Xue Ban = J Peking Univ Health Sci"},{"issue":"4","key":"3815_CR16","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.3390\/ijms24043169","volume":"24","author":"D Pastori","year":"2023","unstructured":"Pastori D, Cormaci VM, Marucci S, et al. A comprehensive review of risk factors for venous thromboembolism: from epidemiology to pathophysiology. Int J Mol Sci. 2023;24(4):3169.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"3815_CR17","first-page":"886","volume":"173","author":"JA Smith","year":"2005","unstructured":"Smith JA. The risk of recurrent venous thromboembolism in men and women. J Urol. 2005;173(3):886\u20137.","journal-title":"J Urol"},{"issue":"12","key":"3815_CR18","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1111\/j.1538-7836.2004.01050.x","volume":"2","author":"T Baglin","year":"2004","unstructured":"Baglin T, Luddington R, Brown K, et al. High risk of recurrent venous thromboembolism in men. J Thromb Haemostasis: JTH. 2004;2(12):2152\u20135.","journal-title":"J Thromb Haemostasis: JTH"},{"issue":"8","key":"3815_CR19","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1177\/09612033241247359","volume":"33","author":"JC Nossent","year":"2024","unstructured":"Nossent JC, Keen HI, Preen DB, et al. Long-term incidence, risk factors and complications for venous thromboembolism in patients with systemic lupus erythematosus. Lupus. 2024;33(8):787\u201396.","journal-title":"Lupus"},{"issue":"34","key":"3815_CR20","first-page":"2419","volume":"92","author":"YD Yuan","year":"2012","unstructured":"Yuan YD, Gong XW, Yang YH. Meta-analysis of risk factors for recurrent pulmonary thromboembolism. Zhonghua Yi Xue Za Zhi. 2012;92(34):2419\u201325.","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"9","key":"3815_CR21","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1182\/blood.2023020727","volume":"143","author":"DW Branch","year":"2024","unstructured":"Branch DW, Lim MY. How I diagnose and treat antiphospholipid syndrome in pregnancy. Blood. 2024;143(9):757\u201368.","journal-title":"Blood"},{"issue":"3","key":"3815_CR22","first-page":"306","volume":"79","author":"WC Yeoh","year":"2024","unstructured":"Yeoh WC, Lim AL. A retrospective review of antiphospholipid syndrome: a single tertiary centre experience. Med J Malay. 2024;79(3):306\u201312.","journal-title":"Med J Malay"},{"issue":"3","key":"3815_CR23","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s40744-023-00538-0","volume":"10","author":"Y Shi","year":"2023","unstructured":"Shi Y, Jiang H, Zhao Y, et al. Immune thrombocytopenia could be an independent clinical phenotype of antiphospholipid syndrome: A prospective cohort study. Rheumatol Therapy. 2023;10(3):649\u201358.","journal-title":"Rheumatol Therapy"},{"issue":"10","key":"3815_CR24","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1161\/ATVBAHA.123.318978","volume":"43","author":"Z Tang","year":"2023","unstructured":"Tang Z, Shi H, Chen C, et al. Activation of platelet mTORC2\/Akt Pathway by Anti-\u03b22GP1 antibody promotes thrombosis in antiphospholipid syndrome. Arterioscleros Thrombos Vasc Biol. 2023;43(10):1818\u201332.","journal-title":"Arterioscleros Thrombos Vasc Biol"},{"key":"3815_CR25","doi-asserted-by":"crossref","unstructured":"Zhou Y, Hu C, Qi W. Anti-\u03b22GPI-domain I antibody is associated with extra-criteria manifestations in a large prospective antiphospholipid syndrome cohort in China. Lupus Sci Med. 2023;10(2):e000924.","DOI":"10.1136\/lupus-2023-000924"},{"issue":"6","key":"3815_CR26","doi-asserted-by":"publisher","first-page":"589","DOI":"10.2169\/internalmedicine.55.5536","volume":"55","author":"K Habe","year":"2016","unstructured":"Habe K, Wada H, Matsumoto T, et al. Presence of antiphospholipid antibodies as a risk factor for thrombotic events in patients with connective tissue diseases and idiopathic thrombocytopenic Purpura. Intern Med (Tokyo Japan). 2016;55(6):589\u201395.","journal-title":"Intern Med (Tokyo Japan)"},{"issue":"4","key":"3815_CR27","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1182\/blood-2007-01-066043","volume":"110","author":"M Galli","year":"2007","unstructured":"Galli M, Borrelli G, Jacobsen EM, et al. Clinical significance of different antiphospholipid antibodies in the WAPS (warfarin in the antiphospholipid syndrome) study. Blood. 2007;110(4):1178\u201383.","journal-title":"Blood"},{"issue":"8","key":"3815_CR28","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1016\/j.jtha.2024.03.027","volume":"22","author":"JE Manning","year":"2024","unstructured":"Manning JE, Arachchillage DJ. Dilemmas in the diagnosis and management of antiphospholipid syndrome. J Thromb Haemostasis: JTH. 2024;22(8):2156\u201370.","journal-title":"J Thromb Haemostasis: JTH"},{"issue":"1","key":"3815_CR29","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1023\/A:1012798713607","volume":"12","author":"BM Alving","year":"2001","unstructured":"Alving BM. Diagnosis and management of patients with the antiphospholipid syndrome. J Thromb Thrombolysis. 2001;12(1):89\u201393.","journal-title":"J Thromb Thrombolysis"},{"issue":"1","key":"3815_CR30","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1055\/s-0043-1769013","volume":"50","author":"A Tufano","year":"2024","unstructured":"Tufano A, Brenner B. Prevention of venous thromboembolism in medical patients with thrombocytopenia or with platelet dysfunction: the last 10 years. Semin Thromb Hemost. 2024;50(1):96\u2013103.","journal-title":"Semin Thromb Hemost"},{"issue":"1","key":"3815_CR31","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1177\/0961203319889156","volume":"29","author":"K Malec","year":"2020","unstructured":"Malec K, Broniatowska E, Undas A. Direct oral anticoagulants in patients with antiphospholipid syndrome: a cohort study. Lupus. 2020;29(1):37\u201344.","journal-title":"Lupus"},{"issue":"SI","key":"3815_CR32","doi-asserted-by":"publisher","first-page":"SI96","DOI":"10.1093\/rheumatology\/kead538","volume":"63","author":"G Ruiz-Irastorza","year":"2024","unstructured":"Ruiz-Irastorza G, Tektonidou MG, Khamashta M. Anticoagulant and non-anticoagulant therapy in thrombotic antiphospholipid syndrome: old drugs and new treatment targets. Rheumatology (Oxford). 2024;63(SI):SI96\u2013106.","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"3815_CR33","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1111\/jcpt.13343","volume":"46","author":"D Wadsworth","year":"2021","unstructured":"Wadsworth D, Sullivan E, Jacky T, et al. A review of indications and comorbidities in which warfarin May be the preferred oral anticoagulant. J Clin Pharm Ther. 2021;46(3):560\u201370.","journal-title":"J Clin Pharm Ther"},{"issue":"5","key":"3815_CR34","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.1097\/MS9.0000000000001999","volume":"86","author":"A Mohtashim","year":"2024","unstructured":"Mohtashim A, Azhar A, Mazhar S, et al. Factor Xa inhibitors vs. warfarin in patients with Hughes syndrome: a systematic review and meta-analysis of randomized controlled trials. Ann Med Surg (2012). 2024;86(5):2992\u20133000.","journal-title":"Ann Med Surg (2012)"},{"issue":"10","key":"3815_CR35","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1177\/0961203315581207","volume":"24","author":"H Cohen","year":"2015","unstructured":"Cohen H, Dor\u00e9 CJ, Clawson S, et al. Rivaroxaban in antiphospholipid syndrome (RAPS) protocol: a prospective, randomized controlled phase II\/III clinical trial of Rivaroxaban versus warfarin in patients with thrombotic antiphospholipid syndrome, with or without SLE. Lupus. 2015;24(10):1087\u201394.","journal-title":"Lupus"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-025-03815-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-025-03815-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-025-03815-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T03:34:51Z","timestamp":1757302491000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-025-03815-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,28]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3815"],"URL":"https:\/\/doi.org\/10.1186\/s12890-025-03815-6","relation":{},"ISSN":["1471-2466"],"issn-type":[{"type":"electronic","value":"1471-2466"}],"subject":[],"published":{"date-parts":[[2025,7,28]]},"assertion":[{"value":"20 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Our study adhered to the Declaration of Helsinki to this effect in the \u2018Ethics approval and consent to participate\u2019 section. Our study has been submitted to and approved by the medical ethics committee of the Affiliated Hospital of Yunnan University. The ethical approval document number is 2024324. Our study utilizes medical records\/biological specimens obtained from previous clinical diagnosis and treatment, and can apply for exemption from informed consent. The Medical Ethics Committee of Yunnan University Affiliated Hospital waives the necessity of agreeing to participate, but the Ethics Committee may also require us to provide research related information to the subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable. We confirm that this work is original and has not been published elsewhere, nor is it currently under consideration for publication elsewhere, all the other coauthors have approved the manuscript that is enclosed, and the article has all necessary institutional approvals.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"357"}}